COVID-19 患者中的肾梗死
本文报告 2 例 COVID-19 感染患者因肾梗死导致肾功能下降,两例均无心房颤动。其中一例接受治疗剂量低分子肝素后肾功能未再恶化。提示 COVID-19 患者急性肾损伤的鉴别诊断应包括肾梗死,可能具有预防和治疗意义。
要点
- COVID-19 患者急性肾损伤鉴别诊断应包括肾梗死
- 肾梗死可发生于无心房颤动的 COVID-19 患者
- 治疗剂量低分子肝素后一例肾功能未再恶化
核心结论
- COVID-19 感染患者发生急性肾损伤时,鉴别诊断应包括肾梗死。
研究设计与样本
- 本文为 2 例病例报告,描述 COVID-19 感染患者因肾梗死出现肾功能下降。
主要发现
- 2 例 COVID-19 患者均无心房颤动,因肾梗死导致肾功能下降。
- 其中 1 例接受治疗剂量低分子肝素后,未再观察到肾功能进一步恶化。
临床怎么用
- 对 COVID-19 合并急性肾损伤患者,应将肾梗死纳入鉴别诊断。
- 肾梗死的识别可能具有预防和治疗意义。
局限性
- 本文仅为 2 例病例报告,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronavirus disease 2019 (COVID-19) is a contagious life-threatening infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent findings indicate an increased risk for acute kidney injury during COVID-19 infection. The pathophysiologic mechanisms leading to acute kidney injury in COVID-19 infection are unclear but may include direct cytopathic effects of the virus on kidney tubular and endothelial cells, indirect damage caused by virus-induced cytokine release, and kidney hypoperfusion due to a restrictive fluid strategy. In this report of 2 cases, we propose an additional pathophysiologic mechanism. We describe 2 cases in which patients with COVID-19 infection developed a decrease in kidney function due to kidney infarction. These patients did not have atrial fibrillation. One of these patients was treated with therapeutic doses of low-molecular-weight heparin, after which no further deterioration in kidney function was observed. Our findings implicate that the differential diagnosis of acute kidney injury in COVID-19-infected patients should include kidney infarction, which may have important preventive and therapeutic implications.
引用
- Post A, den Deurwaarder ESG, Bakker SJL, et al. Kidney Infarction in Patients With COVID-19. Am J Kidney Dis. 2020. PMID: 32479921. doi:10.1053/j.ajkd.2020.05.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。